Joint Venture

December 19, 2018

In, out, in, out, Glaxo shakes consumer health about

Earlier this year Glaxosmithkline looked to be going all-in for consumer health domination, but today it moved to leave the space entirely and focus on the thing that…

January 19, 2018

Snippet roundup: Neurometrix and Foundation Medicine secure big pharma partners

October 18, 2017

Vantage View – Time for Glaxo to decide whether it is a drug developer

May 12, 2017

Guardant enters the record books

August 04, 2016

Interview – Galvani wants to get on patients’ nerves

April 08, 2016

Juno looks east

March 11, 2016

BD spin-out points to more private equity in medtech

January 06, 2016

Fighting over Mannkind’s corpse

November 30, 2015

Copaxone approval gives Teva new leverage in Japan